Please read full Prescribing
Information
for NUPLAZID, including Boxed WARNING.

 

HCP portal  /  Resources

 

we’re here to support your practice and your patients.

 

From help with prior authorizations and benefits investigations to guidance in navigating potential financial support options for your patients, our team is ready to support you.

 
Old-school phone receiver on a slant with a sound bubble coming from its middle

Questions?

Call us at 1-844-737-2223

Monday-Friday, 8:00 AM to 8:00 PM ET

Prescribe & enroll
 
Older man and woman playing a game
 

resources:

 

Getting Started

 
E-prescribing NUPLAZID® with Acadia Connect® Support

E-prescribing NUPLAZID® with Acadia Connect® Support​

 
A white download arrow on a teal backgroundDownload
Acadia Connect® HCP Overview

Acadia Connect® HCP Overview

 
A white download arrow on a teal backgroundDownload
NUPLAZID®: Ready. Set. Connect. Quick Start Guide

NUPLAZID®: Ready. Set. Connect.

 
A white download arrow on a teal backgroundDownload
NUPLAZID® Fact Sheet

NUPLAZID® Fact Sheet

 
A white download arrow on a teal backgroundEnglish A white download arrow on a teal backgroundEspañol
NUPLAZID dosing card

NUPLAZID Dosing Card

 
A white download arrow on a teal backgroundDownload
NUPLAZID® Support Starts Here: A Complete Guide to Acadia Connect®

NUPLAZID® Support Starts Here: A Complete Guide to Acadia Connect®

 
A white download arrow on a teal backgroundDownload
 

Insurance & Coverage Support

 
Letter of Medical Necessity

Letter of Medical Necessity

 
A white download arrow on a teal backgroundDownload
Letter of appeal

Letter of Appeal

 
A white download arrow on a teal backgroundDownload
 

Forms

 
NUPLAZID® Prescription and Enrollment Form

NUPLAZID® Prescription and Enrollment Form

 
A white download arrow on a teal backgroundDownload
NUPLAZID® Authorization for Disclosure of Health Information

NUPLAZID® Authorization for Disclosure of Health Information

 
A white download arrow on a teal backgroundEnglish
NUPLAZID Acadia Connect® Patient/Care Partner Enrollment Form

NUPLAZID Acadia Connect® Patient/Care Partner Enrollment Form

 
A white download arrow on a teal backgroundEnglish
NUPLAZID Acadia Connect® LTC Service Request Form

NUPLAZID Acadia Connect® LTC Service Request Form

 
A white download arrow on a teal backgroundDownload
 
 

Patient Access Manager (PAM).

 

The PAM offers education and support to assist you and your office with accessing NUPLAZID for your patients.

 

The PAM:

  • Provides information to minimize access barriers and coverage delays for NUPLAZID
  • Supports navigating prior authorizations, appeals, and reauthorizations by providing education on plan-specific coverage policies, requirements, and processes
  • Delivers updates on insurance status, potential financial assistance options, and any interruptions in a patient’s potential treatment
 

Contact your PAM.

 

Enter your ZIP code to locate your local PAM.

 
Joe, Patient Access Manager.
Joe, Patient Access Manager.
 
 

contact Acadia Connect®:

 
Old school white phone headset in teal circle
 

Enrollment & Patient Support

 

1-844-737-2223

 

Monday-Friday, 8:00 AM to 8:00 PM ET

 

For patient enrollment, benefits verification, and Care Coordinator inquiries.

Old school white phone headset in teal circle
 

Fax Enrollment Forms

 

1-844-737-2224

 

Available 24/7

 

Fax completed PDF enrollment forms to this number at any time.

 
 

understanding other resources available to patients.

 

Below is a list of resources patients may wish to explore. Please note, this list of independent organizations is provided as an additional resource. The list does not indicate endorsement by Acadia Pharmaceuticals of an organization or its communications.

 

Available Nationally and in Your Area

Organization Name

Contact Information

Services Offered

Parkinson’s Foundation

Available nationally and in your area

parkinson.org

1-800-473-4636

Helpline, care consultation, local support groups, educational resources, and referrals to community services.

Michael J. Fox Foundation for Parkinson’s Research

michaeljfox.org

1-212-509-0995

Research updates, clinical trial matching, care partner resources, and educational programs.

American Parkinson Disease Association (APDA)

apdaparkinson.org

1-800-223-2732

Local chapter support, care consultations, wellness programs, and care partner assistance.

Dave Phinney Foundation

davisphinneyfoundation.org

1-866-358-0285

Provides resources and connections through community programs, the funding of quality-of-life research, and extensive online content.

PMD Alliance

pmdalliance.org

1-800-256-0966

A community working hand-in-hand with those living with a diagnosis, their care partners, adult children, and support group leaders to deliver education and connection to those impacted by movement disorders.

Available Nationally and in Your Area

Parkinson’s Foundation

Available nationally and in your area

 

parkinson.org
1-800-473-4636

 

Helpline, care consultation, local support groups, educational resources, and referrals to community services.

Michael J. Fox Foundation for Parkinson’s Research

 

michaeljfox.org
1-212-509-0995

 

Research updates, clinical trial matching, care partner resources, and educational programs.

American Parkinson Disease Association (APDA)

 

apdaparkinson.org
1-800-223-2732

 

Local chapter support, care consultations, wellness programs, and care partner assistance.

Dave Phinney Foundation

 

davisphinneyfoundation.org
1-866-358-0285

 

Provides resources and connections through community programs, the funding of quality-of-life research, and extensive online content.

PMD Alliance

 

pmdalliance.org
1-800-256-0966

 

A community working hand-in-hand with those living with a diagnosis, their care partners, adult children, and support group leaders to deliver education and connection to those impacted by movement disorders.

 

prescription and enrollment FAQ:

How do I prescribe NUPLAZID and enroll my patient in Acadia Connect®?

There are several ways to prescribe NUPLAZID and connect eligible patients with Acadia Connect® support:

e-Prescribe Through Your Electronic Health Record (EHR)
Select RareMed Solutions in your EHR system when e-prescribing NUPLAZID to submit an electronic prescription directly to Acadia Connect®.

Submit online
Submit the NUPLAZID Prescription and Enrollment Form online through https://acadiaconnect.com/nuplazid/healthcare-providers/enrollment.

Mail, Email, or Fax
Download the NUPLAZID Prescription & Enrollment Form and submit it via:

Mail: PO Box 15713, Pittsburgh, PA 15244

Email: [email protected]

Fax: 1-844-737-2224

What should my patient expect after I submit a prescription to Acadia Connect®?

Once the patient has submitted their consent and enrollment is complete, they will be contacted by a Care Coordinator within the next 2 business days. The Care Coordinator:

  • Helps patients and care partners navigate insurance and the prescription-filling process
  • Provides information on financial support options when needed
  • Coordinates with the patient or care partner and the pharmacy to ensure a timely and convenient delivery of NUPLAZID
What financial support options may be available?

Through the Acadia Connect® Commercial Copay Program, eligible commercially insured patients may pay as little as $0 per month.* For patients who do not have insurance, or have situations in which NUPLAZID is not covered by their insurance plan, Acadia Connect® can provide potential financial assistance options such as the Acadia Connect® Patient Assistance Program.†

*Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal, state, or government-funded healthcare program. Not valid where prohibited by law.

†Terms and conditions apply. An application is required and is subject to review. Submission of an application does not guarantee approval for the program. While Acadia makes every effort to grant aid when needed and appropriate, the program is limited in available resources and may be modified or discontinued at any time without further notice.

How can Acadia Connect® help with insurance, including insurance changes?

Your PAM supports you with access expertise, information about the coverage process, updates on your patient’s insurance status, and specialized coverage resources.

Get Started
 
 

get your patients started today.

 

Submit the NUPLAZID Prescription and Enrollment Form online

 
Prescribe & Enroll
 
Old-school phone receiver on a slant with a sound bubble coming from its middle

Call Acadia Connect®

1-844-737-2223

Monday-Friday, 8:00 AM to 8:00 PM ET

 
Important Safety Information and Indication for NUPLAZID® (pimavanserin)
 
 

Indication

 

NUPLAZID is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

 
Important Safety Information
 
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
 
  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
  • NUPLAZID is not approved for the treatment of patients with dementia who experience psychosis unless their hallucinations and delusions are related to Parkinson’s disease.
 
  • Contraindication: NUPLAZID is contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components. Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported.
  • Warnings and Precautions: QT Interval Prolongation
    • NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval (e.g., Class 1A antiarrhythmics, Class 3 antiarrhythmics, certain antipsychotics or antibiotics).
    • NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and presence of congenital prolongation of the QT interval.
  • Adverse Reactions: The adverse reactions (≥2% for NUPLAZID and greater than placebo) were peripheral edema (7% vs 2%), nausea (7% vs 4%), confusional state (6% vs 3%), hallucination (5% vs 3%), constipation (4% vs 3%), and gait disturbance (2% vs <1%).
  • Drug Interactions:
    • Coadministration with strong CYP3A4 inhibitors increases NUPLAZID exposure. Reduce NUPLAZID dose to 10 mg taken orally as one tablet once daily.
    • Coadministration with strong or moderate CYP3A4 inducers reduces NUPLAZID exposure. Avoid concomitant use of strong or moderate CYP3A4 inducers with NUPLAZID.
 

Please read the full Prescribing Information, including Boxed WARNING, also available at NUPLAZIDhcp.com.

 
 
Dosage and Administration
 

Recommended dose: 34 mg capsule taken orally once daily, without titration, with or without food.

 

NUPLAZID is available as 34 mg capsules and 10 mg tablets.